Table 1.
Patient and tumor characteristics.
| Age | 56.4 (30–78) |
|---|---|
| Gender | |
| Male | 13 (41.9%) |
| Female | 18 (58.1%) |
| Anatomic site | |
| Head/neck | 5 (16.1%) |
| Limbs | 12 (38.7%) |
| Trunk | 12 (38.7%) |
| Not evaluable | 2 (6.5%) |
| Breslow depth | 0.4mm (0.1-1.0) |
| Ulceration | |
| No | 28 (90.3%) |
| Yes | 3 (9.7%) |
| Regression | |
| No | 2 (6.5%) |
| Yes | 20 (64.5%) |
| Not evaluable | 9 (29.0%) |
| Regression at 10% cut off | |
| No | 9 (29.0%) |
| Yes | 13 (41.9%) |
| Not evaluable | 9 (29.0%) |
| TNM† | |
| T1a | 23 (74.2%) |
| T1b | 8 (25.8%) |
| Mitosis‡ | 1.3 (0–4.0) |
| Tumor-infiltrating lymphocytes | |
| Absent | 9 (29.0%) |
| Present | 13 (42.0%) |
| Not evaluable | 9 (29.0%) |
†Staging according to the 8thEdition of AJCC melanoma classification.
‡Number of mitosis per square millimeter.